Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Major Criteria Short stature (progressive in childhood) Muscle hypotonia (ranging from severe congenital to mild later onset) Bowing of limbs Minor Criteria Skin hyperextensibility, soft, doughy skin, thin, translucent skin Pes planus Delayed motor development Osteopenia Delayed cognitive development Gene-Specific Minor Criteria B4GALT7 Radioulnar synostosis Bilateral elbow contractures or limited elbow movement Generalized joint hypermobility Single transverse palmar crease Characteristic craniofacial features Characteristic radiographic findings Severe hypermetropia Clouded cornea B3GALT6 Kyphoscoliosis (congenital or early onset, progressive) Joint hypermobility (generalized or restricted to distal joints, with joint dislocations) Joint contractures (congenital or progressive, especially hands) Peculiar fingers (slender, tapered, arachnodactyly, spatulate, with broad distal phalanges) Talipes equinovarus Characteristic craniofacial features Tooth discoloration, dysplastic teeth Characteristic radiographic findings Osteoporosis with multiple spontaneous fractures Ascending aortic aneurysm Lung hypoplasia, restrictive lung disease SLC39A13 Protuberant eyes with bluish sclerae Hands with finely wrinkled palms Atrophy of the thenar muscles and tapering fingers Hypermobility of distal joints Characteristic radiologic findings FAQs What features suggest a person might have a type of EDS or HSD
Czechia 99.7 % purity confirmed by COA Assay content verified at 12.24 mg Identification confirmed by FTIR and retention time analysis Molecular ion mass identified at 848 Da Endotoxin level below 0.001 EU/mg No detectable heavy metals or microbial contamination DSIP peptide research compound For research use only not for human or veterinary use For laboratory research only
A patient injecting at the wrong time, on an arbitrary schedule, without monitoring is not getting the same protocol
In 2026, the difference between a successful recovery and a dangerous side effect is often the purity of the compound
5-Amino-1MQ selectively inhibits NNMT (IC50 = 1.2 M), an enzyme that consumes nicotinamide by methylating it
PMID: 21658227 Zhang Q, et al
